Immatics (IMTX) Total Non-Current Liabilities (2019 - 2025)

Immatics (IMTX) reported Total Non-Current Liabilities of $41.0 million for Q4 2025, down 28.03% on a YoY basis from $57.0 million in Q4 2024, and down 11.47% sequentially from $46.3 million in Q3 2025.

Immatics (IMTX) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Total Non-Current Liabilities data on file, last reported at $41.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 28.03% year-over-year to $41.0 million; the trailing twelve-month figure through Dec 2025 stood at $41.0 million (down 28.03% YoY), and the FY2025 full-year result was $39.8 million, down 31.03% from the prior year.
  • Total Non-Current Liabilities fell to $41.0 million in Q4 2025, from $46.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $146.1 million in Q4 2023 to a low of $41.0 million in Q4 2025.
  • A 5-year average of $83.3 million and a median of $78.3 million in 2021 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 76.84% in 2022 and slumped 61.01% in 2024, its largest moves.
  • Tracing IMTX's Total Non-Current Liabilities over 5 years: stood at $63.4 million in 2021, then surged by 57.69% to $100.0 million in 2022, then surged by 46.11% to $146.1 million in 2023, then sank by 61.01% to $57.0 million in 2024, then decreased by 28.03% to $41.0 million in 2025.
  • Business Quant data shows IMTX's Total Non-Current Liabilities at $41.0 million in Q4 2025, $46.3 million in Q3 2025, and $51.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Immatics 1.14 Bn 1.14 Bn - 41.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 41.00 Mn
Sep 30, 2025 46.32 Mn
Jun 30, 2025 51.48 Mn
Mar 31, 2025 51.87 Mn
Dec 31, 2024 56.97 Mn
Sep 30, 2024 75.95 Mn
Jun 30, 2024 103.55 Mn
Mar 31, 2024 119.38 Mn
Dec 31, 2023 146.11 Mn
Sep 30, 2023 74.62 Mn
Jun 30, 2023 73.69 Mn
Mar 31, 2023 83.53 Mn
Dec 31, 2022 100.00 Mn
Sep 30, 2022 118.10 Mn
Jun 30, 2022 138.04 Mn
Mar 31, 2022 83.44 Mn
Dec 31, 2021 63.42 Mn
Sep 30, 2021 66.78 Mn
Jun 30, 2021 80.61 Mn
Mar 31, 2021 91.77 Mn